GASTRIC (STOMACH) CANCER
Clinical trials for GASTRIC (STOMACH) CANCER explained in plain language.
Never miss a new study
Get alerted when new GASTRIC (STOMACH) CANCER trials appear
Sign up with your email to follow new studies for GASTRIC (STOMACH) CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Genetically modified immune cells take on eight cancer types in early trial
Disease control OngoingThis early-stage trial tests a personalized cell therapy called ADP-A2M4CD8 in people with certain cancers that have a specific marker (MAGE-A4). The therapy uses a patient's own immune cells, modified to better attack tumors, and is given alone or with standard immunotherapy dru…
Matched conditions: GASTRIC (STOMACH) CANCER
Phase: PHASE1 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New cocktail aims to shrink stomach tumors
Disease control ENROLLING_BY_INVITATIONThis early-stage trial tests whether adding two drugs—pucotenlimab (an immunotherapy) and lenvatinib (a targeted therapy)—to standard chemotherapy (SOX) can shrink tumors better than chemotherapy alone in people with advanced HER2-negative stomach or gastroesophageal junction can…
Matched conditions: GASTRIC (STOMACH) CANCER
Phase: EARLY_PHASE1 • Sponsor: Fujian Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Stool test could spot stomach cancer before it spreads
Diagnosis OngoingThis study looks at whether testing stool (feces) for certain DNA changes and bacteria genes can help find stomach cancer early. Researchers will follow 3000 people, including those with and without cancer, to see how well the test works. The goal is to improve early diagnosis an…
Matched conditions: GASTRIC (STOMACH) CANCER
Sponsor: Fudan University • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC